In melanoma cell lines, 4-nerolidylcatechol (111) is reported as an inhibitor of cell invasiveness, owing to the G1 cell cycle arrest and inhibition of MMP-2 activity.113 Melanoma has a high prevalence of B-RAF mutations. This evidence concerns the gene BRAF and melanoma.